Xilio Therapeutics, Inc. Restructuring Charges
Xilio Therapeutics, Inc. (XLO) reported Restructuring Charges of $937.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-03-23
- Xilio Therapeutics, Inc. restructuring charges for the quarter ending 2024-12-31 was $0.00.
- Xilio Therapeutics, Inc. restructuring charges for the quarter ending 2024-09-30 was -$41.00K.
- Xilio Therapeutics, Inc. restructuring charges for the quarter ending 2024-06-30 was $30.00K.
- Xilio Therapeutics, Inc. restructuring charges for the quarter ending 2024-03-31 was $948.00K.
- Xilio Therapeutics, Inc. restructuring charges for fiscal 2024 was $937.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$41.00K derived: sum of 2 quarters · filed 2026-03-23 | -$11.00K derived: sum of 3 quarters · filed 2026-03-23 | $937.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | -$41.00K 10-Q · filed 2025-11-13 | -$11.00K derived: sum of 2 quarters · filed 2025-11-13 | $937.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $30.00K 10-Q · filed 2025-08-14 | $978.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $948.00K 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |